Nordea Investment Management Ab Arrowhead Pharmaceuticals, Inc. Transaction History

Nordea Investment Management Ab

$85.8 Billion
Q3 2024

A detailed history of Nordea Investment Management Ab transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 124,412 shares of ARWR stock, worth $2.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,412

Previous 129,669 4.05%

Holding current value

$2.44 Million

Previous $3.37 Million 28.55%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$19.36 - $29.54 $101,775 - $155,291	-5,257 Reduced 4.05%	124,412 $2.41 Million
Q2 2024 Aug 08, 2024	SELL	$21.87 - $28.24 $518,056 - $668,949	-23,688 Reduced 15.45%	129,669 $3.37 Million
Q1 2024 May 02, 2024	SELL	$27.21 - $39.48 $76,051 - $110,346	-2,795 Reduced 1.79%	153,357 $4.39 Million
Q4 2023 Jan 10, 2024	SELL	$21.2 - $31.03 $81,344 - $119,062	-3,837 Reduced 2.4%	156,152 $4.78 Million
Q3 2023 Nov 13, 2023	SELL	$26.2 - $36.08 $2,122 - $2,922	-81 Reduced 0.05%	159,989 $4.3 Million
Q2 2023 Jul 07, 2023	BUY	$25.16 - $41.38 $898,564 - $1.48 Million	35,714 Added 28.72%	160,070 $5.71 Million
Q1 2023 Apr 19, 2023	SELL	$23.68 - $38.51 $33,341 - $54,222	-1,408 Reduced 1.12%	124,356 $3.16 Million
Q4 2022 Feb 08, 2023	SELL	$28.0 - $40.56 $198,156 - $287,043	-7,077 Reduced 5.33%	125,764 $5.1 Million
Q3 2022 Oct 19, 2022	SELL	$29.63 - $48.31 $33,718 - $54,976	-1,138 Reduced 0.85%	132,841 $4.51 Million
Q2 2022 Aug 09, 2022	BUY	$27.79 - $50.61 $710,395 - $1.29 Million	25,563 Added 23.58%	133,979 $4.47 Million
Q1 2022 Apr 11, 2022	BUY	$39.62 - $69.97 $42,710 - $75,427	1,078 Added 1.0%	108,416 $5.1 Million
Q4 2021 Jan 20, 2022	SELL	$58.09 - $82.51 $14,987 - $21,287	-258 Reduced 0.24%	107,338 $7.37 Million
Q3 2021 Nov 01, 2021	SELL	$58.38 - $84.96 $6.28 Million - $9.14 Million	-107,596 Reduced 50.0%	107,596 $6.66 Million
Q3 2021 Nov 01, 2021	BUY	$58.38 - $84.96 $8.23 Million - $12 Million	141,037 Added 190.19%	215,192 $13.4 Million
Q2 2021 Jul 16, 2021	BUY	$62.15 - $90.32 $4.14 Million - $6.02 Million	66,681 Added 892.17%	74,155 $6.14 Million
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $458,529 - $676,172	7,474 New	7,474 $500,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Arrowhead Pharmaceuticals, Inc. Transaction History